je fais un don
Fil infos du Groupe ACTION
INFORMATIONS COVID
+
15/02/2009
Impact of anticoagulation regimens on sheath management and bleeding in patients undergoing elective percutaneous coronary intervention in the STEEPLE trial.
Impact of anticoagulation regimens on sheath management and bleeding in patients undergoing elective percuta...
En savoir plus
+
12/11/2008
The use of intravenous enoxaparin in elective percutaneous coronary intervention in patients with renal impairment: results from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial.
The use of intravenous enoxaparin in elective percutaneous coronary intervention in patients with renal impa...
En savoir plus
+
02/09/2008
Dose effect of clopidogrel reloading in patients already on 75-mg maintenance dose: the Reload with Clopidogrel Before Coronary Angioplasty in Subjects Treated Long Term with Dual Antiplatelet Therapy (RELOAD) study.
Dose effect of clopidogrel reloading in patients already on 75-mg maintenance dose: the Reload with Clopidog...
En savoir plus
+
01/02/2008
Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial.
Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervent...
En savoir plus
+
07/09/2007
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention.
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention....
En savoir plus
+
24/01/2007
Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients’ data with long-term follow-up.
Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on in...
En savoir plus
Prec.
1
…
45
46
Suiv.
